Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth Expands US Insurance Coverage for Prostate Cancer Test

NEW YORK (GenomeWeb News) – MDxHealth said today that it has signed up two additional US health insurance providers to cover its prostate cancer test.

Under the agreements, the company's ConfirmMDx for Prostate Cancer test will be covered by HealthSmart, a preferred provider organization network, and Fortified Provider Network.

The company said that with the new agreements more than 135 million people in the US can access the test through their insurance.

HealthSmart is a group of managed healthcare companies that offers products and services to employers, payors, and third-party administrators, and it owns several PPO networks. FPN is a national direct-contracted preferred provider network of more than 200 payor clients and members.

In October, MDxHealth signed up FedMed and America's Choice Provider Network to cover the prostate cancer test.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.